Computational methods have become part of oncology target prioritization workflows at most discovery organizations, but their integration varies widely in practice. Some teams use computational outputs as a primary ranking signal. Others use them as a background reference that occasionally influences but rarely drives selection decisions. Many teams are somewhere in between, with computational outputs entering the discussion without a clear articulated framework for how much weight they should receive.
We think about this integration problem a lot, because the platform we build sits inside these workflows. Here is our current understanding of where computational target prioritization adds genuine value, where it does not replace human judgment, and what the practical workflow integration points look like.
What Computational Methods Are Good At
The strongest case for computational target prioritization is its performance on tasks that involve high-volume data processing with structured classification rules. Retrieving and processing evidence across tens of thousands of papers, applying consistent scoring criteria to all candidates regardless of which internal champion is advocating for them, flagging genomic alteration patterns across large tumor cohort datasets, and surfacing pathway network context from curated databases: these are tasks where computational methods are faster, more consistent, and more comprehensive than manual synthesis.
Speed and consistency together matter more than either alone. A manual evidence review process that is thorough for the three candidates a senior scientist has time to review is less useful for a program that has twenty viable candidates and needs to triage to six for further investigation. The computational layer does not need to be perfect. It needs to be good enough to change which six make it to the detailed review stage, and fast enough to do it before the team meeting where the decision is being made.
Consistency is the less discussed benefit. Evidence synthesis done by different scientists at different times under different time pressures produces different results for the same target. Some of that variation is legitimate scientific judgment. Some of it is attention-dependent: a scientist who reviews a target in the context of a large portfolio review will read the evidence differently than one given a week to do a deep dive. Computational scoring produces the same result for the same evidence regardless of these contextual factors. The consistency does not make it right; it makes it auditable and improvable in ways that variable manual assessment is not.
Where Human Judgment Remains Essential
The complementary case is equally important to understand. Computational methods operating on literature and public datasets are bounded by what those sources contain and how well the extraction has been performed. There are categories of scientific knowledge that matter for target selection but do not live in the public literature in forms that are computationally accessible.
Internal program knowledge is the most significant. A discovery team that has been working in a therapeutic area for two years has accumulated assay results, failed screens, chemistry observations, and mechanistic hypotheses that are not in any publication. Some of this knowledge is positive for specific candidates. Some of it is negative and represents the hidden curriculum of what has been tried and has not worked. Computational prioritization that operates only on public data cannot incorporate this. The team's internal evidence has to be weighted by the people who hold it.
Strategic context is another category where computational methods provide no direct input. A target that scores well on evidence quality may not be the right target for a specific organization at a specific stage of capability development. Intellectual property landscape, competitive positioning, the organization's medicinal chemistry strength in a particular target class, and the organization's clinical development capabilities all shape which targets represent good opportunities for a specific team. These are not derivable from evidence quality scores.
The practical recommendation we give to teams is to treat computational prioritization as a structured input to the target selection decision, not as the output of the target selection decision. The computational analysis narrows the candidate set and surfaces evidence-quality information that is hard to assemble manually at scale. The selection decision incorporates that analysis alongside internal program knowledge, strategic context, and the scientific judgment of people who know the field in ways that go beyond the public literature.
Common Integration Failure Modes
In practice, computational methods tend to fail in their integration with discovery workflows for one of a few recurring reasons. Understanding the failure modes helps in designing the integration to avoid them.
The most common failure is timing. Computational analysis outputs that arrive after the informal target shortlist has already formed do not change the decision; they confirm or rationalize it. For computational prioritization to affect which targets advance, it has to be available at the point where the candidate set is still open. If the team has already committed informally to five targets before the computational scoring is run, the scoring is post-hoc justification. This means building the computational step into the process at the point of early candidate generation, not at the point of final validation.
A second common failure is opacity. If the computational output is a ranked list without visible scoring rationale, teams without high computational confidence will often use it selectively: accepting outputs that confirm existing preferences, questioning outputs that challenge them. This is a natural human response to opaque rankings, and it is not wrong. The solution is not to demand that teams trust the computation. It is to make the scoring rationale visible enough that teams can evaluate which dimensions they agree with and which they want to interrogate further. A score with attribution is usable. A score without it is just a number.
A third failure is asking computational methods to do things they cannot do. Using a literature-based evidence score as a proxy for druggability, or using genomic alteration frequency as a proxy for mechanistic functional validation, miscalibrates the decision by treating one evidence type as if it were another. Each dimension of the evidence base says something specific and should be used for what it says.
What the Workflow Integration Looks Like in Practice
For a discovery team working through an annual target selection cycle, the integration point we find most useful is at the candidate generation phase, before candidates have been assigned to individual scientists for deep review. At this stage, the computational analysis serves as a high-throughput filter that characterizes the evidence landscape for all viable candidates consistently and surfaces the ones whose evidence profiles warrant deeper human investigation.
The output of that filter should be a structured characterization of each candidate, not just a ranking. What is the functional evidence breadth? Is the clinical context evidence subtype-specific or population-level? Where does the pathway context point? What is the evidence trajectory over recent publications, is the field growing in this area or has interest plateaued? These characterizations support the human review that follows rather than replacing it.
The deep human review then focuses on the subset of candidates that the computational filter identified as evidence-rich and evidence-coherent, adds the internal program knowledge and strategic context that the computational layer cannot provide, and makes the nomination decision. The computational layer has changed which candidates receive the deep human review, not who makes the final call.
This is the workflow design Avenzo is built for. If your team is at a point where the target candidate list has outgrown what manual evidence synthesis can handle within your planning cycle, and you want to understand how computational evidence scoring would change the early filter in your process, reach out to discuss your program's specific setup.